Results for "Telix Pharmaceuticals"

Telix Pharmaceuticals Limited held its Q2 2026 earnings call, summarizing its financial performance for the quarter.

Telix Pharmaceuticals has released its second-quarter results and provided an updated outlook for its fiscal year 2026, detailing its financial performance and future projections.

Regeneron Pharmaceuticals (REGN) has announced a new collaboration agreement with Telix Pharmaceuticals Limited, signaling a joint effort in pharmaceutical development.

Telix Pharmaceuticals saw its stock increase after its imaging agent for brain cancer received a review designation from the U.S. Food and Drug Administration (FDA).

Telix Pharmaceuticals Limited held its Q4 2025 earnings call, summarizing its financial performance.

Multiple companies, including EQ, Urbanfund, Ping An Insurance, Appulse, Telix Pharmaceuticals, VGP SA, and Exasol AG, have released their half-year financial results, detailing their earnings per share and revenue.

Telix Pharmaceuticals and United Imaging Healthcare have announced a strategic research partnership focused on advancing theranostics, combining diagnostics and therapy.

Telix Pharmaceuticals has dosed the first patient in its Phase 3 clinical trial for a new brain cancer therapy. This marks a significant step in the development of potential treatments for glioblastoma.

Telix Pharmaceuticals announced its first-quarter financial results, confirming its previously stated outlook for fiscal year 2026.

Telix Pharmaceuticals' second-half earnings call highlights have been published, providing an overview of the company's financial results.

Telix Pharmaceuticals' first-half earnings call presented significant highlights concerning its financial results and operational achievements.

Wall Street analysts are reportedly bullish on Telix Pharmaceuticals (TLX), with the article detailing the reasons for this positive outlook.

Telix Pharmaceuticals reported a GAAP EPS of -$2.11, missing estimates by $2.14, with revenue of $803.8 million also falling short by $22.79 million.